Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...

Eli Lilly and Co. (LLY) on Thursday reported fourth-quarter earnings of $4.41 billion. The Indianapolis-based company said it had profit of $4.88 per share. Earnings, adjusted for one-time gains and ...

The Indianapolis-based drugmaker reported sales ... which owns Lilly's shares. Eli Lilly also forecast annual profit largely above Wall Street estimates on Thursday, saying it expects to earn ...

Eli Lilly’s profit doubled in the fourth quarter ... States as a treatment for some forms of sleep apnea. For 2025, the Indianapolis drugmaker expects adjusted earnings to range between $ ...

The Indianapolis-based drugmaker reported sales for its Zepbound ... chief operating officer at Bahl & Gaynor, which owns Lilly's shares. Eli Lilly also forecast annual profit largely above Wall ...